Pharmaceutical Case Studies
Therapy Area/Business Area
Alternative Pharmaceutical Ingredients/Business Development and Licensing
The Business Issue
- To assist in the identification of the current market opportunity for synthetic processes for Chiral drugs/Chiral Epoxide and Chiral Diols
- To assist in the identification of the pipeline drug candidates against the backdrop opportunity of synthetic processes for Chiral drugs
The Impact
- Provided a detailed assessment of the Chiral Epoxide technology in the market
- Identified the opportunity for the client to develop Chiral technology beyond its own HKR technology platform
The SmartAnalyst Approach
- Provide a detailed scope for collaboration with client, constructed in three phases
- Provide project milestones and key touch-points
- Focus on identifying specific Chiral technologies that fit the client’s criteria across marketed compounds and Phase 2&3 compounds
- Subsequent analysis of compounds synthesized using Asymmetric Synthesis
The Output (7 week turnaround)
- Provide a comprehensive review of technology compounds and the technology market size – across Chiral Epoxide, Chiral Diols
- Identify the technology that gives access to Chiral drugs
- Identify the compounds that best fit with the clients technology (plus review pipeline for other technology fits – opportunity potential)
Intelligent Insights. Smart Results.
